US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles — Niles, Illinois

US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles is a clinical research site located in Niles, Illinois, United States 60714.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Niles

Browse all research sites in Illinois · View every site in Niles

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles?

US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles conducted?

US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia.

Is US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles accredited by Crixeo Clinical Trials?

US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.